Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

EBS holding history

Emergent BioSolutions Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EBS overviewAll 13F holders of EBSFull Q2 2026 holdings

Shares (Q2 2026)
900,108
Value
$7.54M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of EBS by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026900,108$7.54M<0.1%−103,804−10.3%ReducedHolders
Q1 20261,003,912$8.33M<0.1%+280,695+38.8%AddedHolders
Q4 2025723,217$8.94M<0.1%+402,050+125.2%AddedHolders
Q3 2025321,167$2.83M<0.1%−90,201−21.9%ReducedHolders
Q2 2025411,368$2.62M<0.1%+139,094+51.1%AddedHolders
Q1 2025272,274$1.32M<0.1%−110,769−28.9%ReducedHolders
Q4 2024383,043$3.66M<0.1%−388,095−50.3%ReducedHolders
Q3 2024771,138$6.44M<0.1%−56,658−6.8%ReducedHolders
Q2 2024827,796$5.65M<0.1%+411,132+98.7%AddedHolders
Q1 2024416,664$1.05M<0.1%−769,888−64.9%ReducedHolders
Q4 20231,186,552$2.85M<0.1%+250,034+26.7%AddedHolders
Q3 2023936,518$3.18M<0.1%−41,399−4.2%ReducedHolders
Q2 2023977,917$7.19M<0.1%−385,863−28.3%ReducedHolders
Q1 20231,363,780$14.1M<0.1%−267,838−16.4%ReducedHolders
Q4 20221,631,618$19.3M<0.1%+639,405+64.4%AddedHolders
Q3 2022992,213$20.8M<0.1%−73,734−6.9%ReducedHolders
Q2 20221,065,947$33.1M0.1%−97,639−8.4%ReducedHolders
Q1 20221,163,586$47.8M0.1%+218,248+23.1%AddedHolders
Q4 2021945,338$41.1M0.1%+882,893+1,413.9%AddedHolders
Q3 202162,445$3.13M<0.1%+52,852+550.9%AddedHolders
Q2 20219,593$604.0K<0.1%+9,593NewHolders